Terug
Ook genoteerd als
GGNDF
OTC
Dagbereik
€ 44,03
€ 44,10
52-Weeksbereik
€ 36,83
€ 57,22
Volume
1
50D / 200D Gem.
€ 47,63
/
€ 49,03
Vorige Slotkoers
€ 44,68
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 3,3 | 0,3 |
| P/B | 0,2 | 3,0 |
| ROE % | 6,0 | 3,7 |
| Net Margin % | 3,9 | 3,8 |
| Rev Growth 5Y % | 1,6 | 10,0 |
| D/E | 1,0 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 5,41
€ 5,41 – € 5,41
|
20,62B | 1 |
| FY2029 |
€ 5,54
€ 5,54 – € 5,54
|
19,79B | 1 |
| FY2028 |
€ 5,53
€ 5,53 – € 5,53
|
18,97B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-05 | € 1,36 | € 1,10 | -19,1% |
| 2025-11-06 | € 0,64 | € 0,23 | -63,8% |
| 2025-08-21 | € 0,58 | € 0,52 | -10,3% |
| 2025-04-30 | € 0,73 | € 0,21 | -71,1% |
| 2025-02-06 | € 1,30 | € 1,08 | -16,9% |
| 2024-11-07 | € 0,76 | € 0,82 | +7,5% |
| 2024-08-22 | € 0,53 | € 0,29 | -45,3% |
| 2024-05-02 | € 0,43 | € 0,76 | +76,6% |
Dividend History
Yield
0,01%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 1,56% annually over 5 years — modest growth
Earnings declined -33,91% over the past year
Generating 1,14B in free cash flow
P/E of 3,28 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 8,25%
Cash machine — converts 174,12% of earnings into free cash flow
Groei
Revenue Growth (5Y)
1,56%
Revenue (1Y)-6,69%
Earnings (1Y)-33,91%
FCF Growth (3Y)-2,90%
Kwaliteit
Return on Equity
6,01%
ROIC5,51%
Net Margin3,89%
Op. Margin9,51%
Veiligheid
Debt / Equity
0,99
Current Ratio1,18
Interest Coverage2,57
Waardering
P/E Ratio
3,28
Forward P/EN/A
P/B Ratio0,20
EV/EBITDA7,42
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6,69% | Revenue Growth (3Y) | -3,76% |
| Earnings Growth (1Y) | -33,91% | Earnings Growth (3Y) | 69,23% |
| Revenue Growth (5Y) | 1,56% | Earnings Growth (5Y) | -21,91% |
| Profitability | |||
| Revenue (TTM) | 16,78B | Net Income (TTM) | 653,00M |
| ROE | 6,01% | ROA | 2,23% |
| Gross Margin | 54,56% | Operating Margin | 9,51% |
| Net Margin | 3,89% | Free Cash Flow (TTM) | 1,14B |
| ROIC | 5,51% | FCF Growth (3Y) | -2,90% |
| Safety | |||
| Debt / Equity | 0,99 | Current Ratio | 1,18 |
| Interest Coverage | 2,57 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 3,28 | Forward P/E | N/A |
| P/B Ratio | 0,20 | P/S Ratio | 0,13 |
| PEG Ratio | -0,65 | Forward PEG | N/A |
| EV/EBITDA | 7,42 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 53,12% | ||
| Market Cap | 2,14B | Enterprise Value | 11,84B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 16,78B | 17,99B | 18,12B | 18,69B | 15,78B |
| Net Income | 653,00M | 988,00M | 228,00M | 511,00M | 1,76B |
| EPS (Diluted) | 12,93 | 20,34 | 4,92 | 11,97 | 40,47 |
| Gross Profit | 9,16B | 9,56B | 9,04B | 9,13B | 8,68B |
| Operating Income | 1,60B | 1,86B | 869,00M | 1,11B | 2,40B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 29,23B | 30,61B | 30,64B | 30,59B | 23,55B |
| Total Liabilities | 18,33B | 19,79B | 21,06B | 23,79B | 17,32B |
| Shareholders' Equity | 10,90B | 10,82B | 9,59B | 6,80B | 6,23B |
| Total Debt | 10,82B | 11,49B | 13,50B | 16,25B | 11,57B |
| Cash & Equivalents | 1,12B | 980,00M | 2,16B | 990,00M | 6,21B |
| Current Assets | 8,64B | 9,33B | 10,18B | 9,37B | 11,99B |
| Current Liabilities | 7,32B | 8,15B | 15,64B | 11,73B | 6,14B |